YTHDF2 alleviates diabetic cardiomyopathy by targeting m6A-mediated degradation of lncRNA RMRP and inhibiting NLRP3-dependent pyroptosis
Fields of Study & Subjects
RNA modifications and cancer
Inflammasome and immune disorders
interferon and immune responses
Publication details
- Journal / source
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Volume
- 248
- Pages
- 117860–117860
- Publication date
- 3 March 2026
- Language
- EN